Search This Blog

Monday, March 11, 2019

TCR2 Therapeutics initiated at Jefferies

TCR2 Therapeutics initiated with a Buy at Jefferies. Jefferies analyst Biren Amin started TCR2 Therapeutics with a Buy rating and $31 price target.
https://thefly.com/landingPageNews.php?id=2876919
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)